iridium has been researched along with Neoplasms in 147 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 57 (38.78) | 18.7374 |
| 1990's | 1 (0.68) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 40 (27.21) | 24.3611 |
| 2020's | 49 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fei, W; Hao, J; Li, W; Liu, Y; Tian, L; Yuan, Y; Zhang, H; Zhang, Y; Zhou, Y | 1 |
| Banerjee, S; Fan, Z; Huang, C; Huang, H; Li, T; Li, W; Liang, C; Raghavachari, K; Sadhukhan, T; Xie, J; Zhang, P | 1 |
| Aoki, S; Balachandran, C; Haribabu, J; Naito, K; Tamura, Y; Tobita, S; Tsuchiya, K; Umezawa, M; Yokoi, K; Yoshihara, T | 1 |
| Li, ZY; Ling, YY; Mao, ZW; Tan, CP; Wang, WJ; Zhong, YM | 1 |
| Chao, H; Gasser, G; Ji, L; Karges, J; Ke, L; Kuang, S; Liao, X; Wei, F; Xiong, K | 1 |
| Geisler, H; Harringer, S; Jakupec, MA; Kandioller, W; Keppler, BK; Urban, R; Wenisch, D | 1 |
| Banerjee, S; Fan, Z; Guo, S; Huang, H; Ji, S; Kushwaha, R; Li, W; Liang, S; Raghavachari, K; Rong, Y; Sadhukhan, T; Wang, J; Yuan, Z; Zhu, Z | 1 |
| Bose, B; Das, U; De, S; Kar, B; Kumar S K, A; Nagendra, AH; Paira, P; Panda, D; Pete, S; Roy, N; Sahoo, SK; Shanavas, S; Sharma S, A; Shenoy, S; Vardhan, S | 1 |
| Barrabés, S; Echevarría, I; Espino, G; Jalón, FA; Manzano, BR; Martínez, MÁ; Massaguer, A; Ortega, N; Quesada, R; Ramos-Gómez, S; Zafon, E | 1 |
| Cai, X; Chen, J; Chen, L; Chen, W; Guo, X; Huang, H; Liang, C; Luo, H; Sun, Q; Tang, H | 1 |
| Li, ZY; Mao, ZW; Shen, QH; Tan, CP | 1 |
| Chen, X; Li, S; Mao, ZW; Shen, J; Zhang, H | 1 |
| Banerjee, S; Carter, OWL; Huang, H; Lai, Y; Sadler, PJ; Wei, L; Zhu, Z | 1 |
| Cao, H; Chen, D; Fang, Z; Lu, X; Shao, T; Tian, X; Tian, Y; Zhao, H | 1 |
| Cutillas, N; Gandía-Herrero, F; Henarejos-Escudero, P; Hernández-García, S; Ortega-Forte, E; Ruiz, J; Vigueras, G | 1 |
| Cai, X; Hu, B; Meng, Z; Nie, T; Wang, L; Wu, J; Ying, T; Zheng, Y; Zou, W | 1 |
| Bochkarev, LN; Klapshina, LG; Komarova, AD; Konev, AN; Kovylina, TA; Mozherov, AM; Parshina, YP; Plekhanov, AA; Shchechkin, ID; Shcheslavskiy, VI; Shirmanova, MV; Sirotkina, MA | 1 |
| Hao, L; Liang, JH; Ling, YY; Mao, ZW; Tan, CP; Wang, WJ; Wu, XW; Zhang, H | 1 |
| Cai, X; Chen, Y; Huang, L; Jiang, L; Nie, T; Wang, L; Wu, J; Ying, T; Zheng, Y; Zhou, Y | 1 |
| Bijani, C; Cuvillier, O; Deraeve, C; Gornitzka, H; Hemmert, C; Maddelein, ML; Madji, R; Mazères, S; Voros, C; Wang, X; Zhang, C | 1 |
| Chen, X; Cheng, J; Dai, Y; Jin, D; Li, L; Liu, M; Liu, Y; Sun, Y; Yu, J; Yu, W; Zhu, Y; Zou, J | 1 |
| Aoki, S; Imura, T; Kanbe, A; Yasuda, Y; Yokoi, K | 1 |
| Christofferson, AJ; Engel, GS; Ghosh, I; Lin, G; Lin, W; Liu, G; Luo, T; Nash, GT; Sohoni, S | 1 |
| Burton, AJ; Kleiner, RE; Lee, G; MacMillan, DWC; Muir, TW; Seath, CP; Sun, X | 1 |
| Kim, JS; Liu, M; Luo, Y; Xing, X; Xiong, X; Yan, J; Zou, T | 1 |
| Chen, G; He, Z; Li, X; Li, Y; Miao, Y; Wang, X; Yang, Z; Zhang, D; Zhang, Y; Zheng, L | 1 |
| Chao, H; Chen, Y; Feng, T; He, Y; Ji, L; Jin, C; Karges, J; Pan, Y; Shen, J; Tang, Z | 1 |
| Ali, B; Guo, W; He, J; Liao, F; Wang, M; Yao, Y; Zhang, DY; Zhao, Z; Zheng, Y; Zhuang, J | 1 |
| Chen, X; Liu, Z; Ma, W; Tian, Z; Xia, X; Xu, Z; Zhang, S; Zhang, Y | 1 |
| Cameron, CG; Colón, KL; Jabed, MA; Kilina, S; Liu, B; McFarland, SA; Monro, S; Sun, W; Xu, W | 1 |
| Chen, Y; Guo, J; Huo, M; Wang, L; Xu, H; Zhang, T | 1 |
| Carrasco, AC; Carrascosa, JL; Cloetens, P; Conesa, JJ; Pereiro, E; Pizarro, AM; Rodríguez-Fanjul, V; Yang, Y | 1 |
| Balónová, B; Blight, BA; Cinatl, J; Michaelis, M; Serpell, CJ; Thomas, SJ; Wass, MN | 1 |
| Barceló-Oliver, M; Fiol, JJ; Franconetti, A; Frontera, A; García-Raso, A; Lorenzo, J; Ortega-Castro, J; Rodríguez-Calado, S; Terrón, A; Vázquez-López, EM | 1 |
| Hu, W; Jia, X; Jiang, X; Liu, Y; Wang, C; Wang, W; Zhang, M; Zhen, W | 1 |
| Lu, N; Luo, Y; Zhang, P; Zhang, Q | 1 |
| Li, L; Li, Y; Tong, X; Xie, Z; Yang, Z; Zhang, L; Zhu, D | 1 |
| Cui, L; Du, J; Wang, C; Yang, H; Yang, S; Zhai, T; Zhou, Z | 1 |
| Cao, Q; Fang, HJ; Mao, ZW; Yang, J | 1 |
| Bai, L; Gu, Y; Hao, J; Liu, Y; Tian, L; Wen, H; Zhang, H; Zhang, Y; Zhou, Y | 1 |
| Bose, B; Gauthaman, A; Moharana, P; Moorthy, A; Muthukumar, V; Paira, P; Ray Chaudhuri, S; Roy, N; Sen, U | 1 |
| Shimada, A; Shiozaki, S; Tobita, S; Yasukagawa, M; Yoshihara, T | 1 |
| Mao, ZW; Shen, J; Zhang, DY; Zhang, H | 1 |
| Chao, XJ; Liu, B; Liu, LY; Ma, W; Mao, ZW; Pan, Q; Qi, G; Wang, KN; Yu, Z | 1 |
| Huang, L; Jiang, L; Lan, M; Peng, X; Wang, Y; Wu, X; Yang, K; Yi, XY; Zhao, S; Zhou, Y | 1 |
| Chen, H; He, J; Huang, H; Lai, Y; Liang, C; Luo, S; Pan, Z; Ren, Q; Xie, J; Zhang, P; Zhang, Q | 1 |
| Chao, H; Chen, Y; Ji, L; Karges, J; Shen, J; Xiong, K | 1 |
| Chen, H; Cui, P; Deng, Y; Guo, Z; Jiao, J; Liu, B; Sun, W; Xu, W; Zhang, M | 1 |
| Fei, Z; Jiang, Q; Luo, K; Wang, S; Wu, H; Xie, M; Zhao, J; Zhu, C | 1 |
| De Palo, A; Draca, D; Maksimovic-Ivanic, D; Marchetti, F; Mijatovic, S; Murrali, MG; Pampaloni, G; Zacchini, S | 1 |
| Chang, KH; Chen, YT; Chou, PT; Chu, CY; Grachova, EV; Jänis, J; Kisel, KS; Koshevoy, IO; Liu, TM; Shakirova, JR; Shen, YF; Thangavel, MK; Tsai, MR; Tunik, SP; Wu, CH; Wu, PC; Zhang, Z | 1 |
| Cai, Z; Cong, F; Wei, Y; Xie, Y; Zhang, H | 1 |
| Carragher, NO; Hearn, JM; Hughes, GM; Liu, Z; Munro, AF; Romero-Canelón, I; Rubio-Ruiz, B; Sadler, PJ | 1 |
| Bevernaegie, R; De Winter, J; Elias, B; Gerbaux, P; Hanan, GS; Laramée-Milette, B; Marcélis, L; Robeyns, K | 1 |
| Chai, R; Du, T; Jiang, H; Rehman, FU; Shaikh, S; Wang, X; Yin, L | 1 |
| Banerjee, S; Huang, H; Sadler, PJ | 1 |
| Eskandari, A; Laws, K; Lu, C; Suntharalingam, K | 1 |
| Chen, Z; Huang, W; Liu, S; Meng, X; Shi, Y; Song, L; Zhao, M; Zhao, Q; Zou, L | 1 |
| Huang, T; Huang, W; Liu, S; Yu, Q; Zhang, KY; Zhao, Q | 1 |
| Ge, X; Hao, H; Liu, X; Liu, Z; Ren, T; Tian, X; Wang, Y; Zhao, C; Zhao, Y | 1 |
| Casari, I; Desai, NM; Falasca, M; Massi, M; Simpson, PV | 1 |
| Brabec, V; Bresolí-Obach, R; Galindo, A; Gandioso, A; Hally, C; Kasparkova, J; Kostrhunova, H; Marchán, V; Markova, L; Nonell, S; Novohradsky, V; Rovira, A; Ruiz, J; Svitelova, M; Vigueras, G | 1 |
| Cao, JJ; Ji, LN; Mao, ZW; Tan, CP; Wang, FX; Wu, XW; Zhang, DY; Zhang, H; Zheng, Y | 1 |
| Lai, XY; Liu, YT; Wang, X; Yin, X | 1 |
| Gao, Y; Jin, H; Lin, J; Yang, H; Yang, Q; Yang, S | 1 |
| Hou, L; Lu, Z; Wang, J; Xie, Z; Yi, S; Zhang, J | 1 |
| Du, Q; Ge, X; Guo, L; Liu, X; Liu, Z; Tian, Z; Zhang, F; Zhao, L | 1 |
| Gao, W; Ge, X; Li, J; Liu, Z; Xu, Z; Zhang, S | 1 |
| Hands-Portman, I; Hearn, JM; Liu, Z; Qamar, B; Romero-Canelón, I; Sadler, PJ | 1 |
| Guo, Y; Jia, M; Liu, Y; Shang, J; Wu, D; Xu, J; Zeng, Y; Zhang, S | 1 |
| Foda, MF; Han, HY; Huang, L; Shao, F | 1 |
| Buckle, T; Jalink, K; Oikonomou, M; Raspe, M; Rood, MT; Urano, Y; van Leeuwen, FW; Velders, AH | 1 |
| Chen, MH; He, L; Ji, LN; Mao, ZW; Tan, CP; Ye, RR | 1 |
| Lu, Y; Qin, L; Shi, M; Xue, F; Yan, Y; Yang, H; Yang, S; Zhou, Z | 1 |
| Berdis, AJ; Choi, JS; Gray, T; Maity, A | 1 |
| Allison, SJ; Hebden, AJ; Henderson, IR; Lord, RM; McGowan, PC; Pask, CM; Phillips, RM; Shepherd, SL | 1 |
| Chao, H; Chen, X; Chen, Y; Ji, L; Jin, C; Li, G; Sun, L | 1 |
| Che, WI; Chen, XP; He, B; Leung, CH; Liu, LJ; Lu, JJ; Ma, DL; Mao, Z; Miles, JA; Wang, W; Wilson, AJ | 1 |
| Chao, H; Chen, Y; Guan, RL; Ji, LN; Ouyang, C; Xiong, K | 1 |
| Tobita, S; Yoshihara, T | 1 |
| Baggaley, E; Bonneau, M; Bryant, HE; Guerchais, V; McKenzie, LK; Sazanovich, IV; Weinstein, JA; Williams, JA | 1 |
| Chen, MH; Hu, XY; Ji, LN; Mao, ZW; Tan, CP; Wang, FX; Ye, RR | 1 |
| Abe, R; Aoki, S; Hisamatsu, Y; Masum, AA; Sato, A; Shibuya, A; Suzuki, N; Tanuma, SI | 1 |
| Chatani, M; Kumita, S; Nose, T; Otani, Y; Teshima, T | 1 |
| Cieslak, M; Donevski, S; Kazmierczak-Baranska, J; Lorenz, IP; Nawrot, B; Rohbogner, CJ; Wirth, S | 1 |
| Hosaka, M; Iida, Y; Negishi, K; Takeuchi, T; Tobita, S; Yoshihara, T; Zhang, S | 1 |
| Hartinger, CG | 1 |
| Guo, Y; Li, C; Lin, J; Zhang, S | 1 |
| CHASSAGNE, D; PIERQUIN, B | 2 |
| SIMON, N | 4 |
| GREGORIO, RG | 1 |
| CHASSAGNE, D; FLAISLER, A; JANVIER, L; PIERQUIN, B | 1 |
| DICKSON, RJ | 1 |
| MAEDA, T | 1 |
| HENSHKE, UK; HILARIS, BS; MAHAN, GD; PROIMOS, BS | 1 |
| ALEXANDER, L; BENEVENTANO, TC | 1 |
| DRAKE, CG; LINELL, EA; PFALZNER, PM | 1 |
| HENSCHKE, UK; HILARIS, BS; MAHAN, GD | 1 |
| PIERQUIN, B | 5 |
| LIEGNER, LM | 1 |
| BRASFIELD, RD; HENSCHKE, UK | 1 |
| BRASFIELD, RD; DASGUPTA, T; HENSCHKE, UK | 1 |
| CHASSAGNE, D; PAUNIER, JP; PIERQUIN, B | 1 |
| Henschke, UK | 1 |
| Ambesi Impiombato, G; Nervi, C | 1 |
| Emami, B; Leybovich, L; Marks, JE; Nussbaum, GH; Perez, CA; Von Gerichten, D | 1 |
| Archambeau, J; Astrahan, M; Forell, B; George, FW; Joseph, CD; Lipsett, J | 1 |
| Veraguth, P | 1 |
| Walker, MA | 1 |
| Chassagne, D; Cosset, JM; Gerbaulet, A | 1 |
| Breschi, R; Bruni, F; De Maio, G; Ficari, A; Villa, P | 1 |
| Feroldi, P; Gallini, R; Verzeletti, L | 1 |
| Lucas, K | 1 |
| Feder, BH; Syed, AM | 1 |
| Scott, WP | 1 |
| Dańczak-Ginalska, Z | 1 |
| Bourland, JD; Chaney, EL; McMurry, HL; Reynolds, KL; Rosenman, JG; Simons, AD; Varia, MA | 1 |
| Cross, P; Denham, JW | 1 |
| Alth, G; Neubauer, J | 1 |
| Chassagne, D; Flamant, F; Gerbaulet, A; Panis, X | 1 |
| Findley, DO; Forell, BW | 1 |
| Leung, S; Marinello, G; Pierquin, B; Valero, M | 1 |
| Eschwège, F; Le Bourgeois, JP; Schlienger, M | 1 |
| Jones, TD | 1 |
| Kramer, S; Mansfield, CM; Stella, JG; Suntharalingam, N | 1 |
| Payne, JH | 1 |
| Bloquel, J; Couette, JE; Gazengel, P; Larra, F; Robillard, J | 1 |
| Coopmans De Yoldi, G | 1 |
| Sauerwein, K | 1 |
| Ellis, F | 1 |
| Gamble, D | 1 |
| Chassagne, D; Cox, JD; Pierquin, B | 1 |
| Sinistrero, G | 1 |
| Henschke, UK; Hilaris, BS; Holt, JG | 1 |
| Feine, U; Koburg, E | 1 |
| Paunier, JP | 1 |
| Bercy, A | 1 |
8 review(s) available for iridium and Neoplasms
| Article | Year |
|---|---|
Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy.
Topics: Antineoplastic Agents; Coordination Complexes; Humans; Immunotherapy; Iridium; Neoplasms; Ruthenium | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Microenvironment-sensitive iridium(iii) complexes for disease theranostics.
Topics: Animals; Antineoplastic Agents; Coordination Complexes; Diabetes Mellitus; Humans; Hypoglycemic Agents; Iridium; Neoplasms; Theranostic Nanomedicine; Tumor Microenvironment | 2020 |
Recent Advances in the Design of Targeted Iridium(III) Photosensitizers for Photodynamic Therapy.
Topics: Animals; Coordination Complexes; Drug Design; Humans; Iridium; Models, Molecular; Molecular Targeted Therapy; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2018 |
Metal-based antitumor compounds: beyond cisplatin.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Copper; Drug Discovery; Gold; Humans; Iridium; Iron; Metals; Neoplasms; Organometallic Compounds; Rhenium; Rhodium; Ruthenium | 2019 |
Intracellular and in vivo oxygen sensing using phosphorescent iridium(III) complexes.
Topics: Cell Line, Tumor; Humans; Iridium; Luminescence; Neoplasms; Oxygen | 2016 |
Interstitial implant brachytherapy in small animals.
Topics: Animals; Brachytherapy; Cat Diseases; Cats; Dog Diseases; Dogs; Iridium; Iridium Radioisotopes; Isotopes; Neoplasms; Radiation Effects; Radiation Oncology; Radiotherapy Dosage; Radiotherapy, Computer-Assisted | 1997 |
Present status of radium.
Topics: Cervix Uteri; Cesium Isotopes; Cobalt Radioisotopes; Endometrium; Female; Gold Isotopes; Iodine Radioisotopes; Iridium; Miniaturization; Neoplasms; Radiation Dosage; Radioisotopes; Radiotherapy, High-Energy; Radium; Uterine Cervical Neoplasms; Uterine Neoplasms | 1974 |
1 trial(s) available for iridium and Neoplasms
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
139 other study(ies) available for iridium and Neoplasms
| Article | Year |
|---|---|
Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Carriers; Drug Liberation; Drug Screening Assays, Antitumor; Humans; Iridium; Liposomes; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neoplasms; NIH 3T3 Cells; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints; Xenograft Model Antitumor Assays | 2021 |
Highly Efficient Ir(III)-Coumarin Photo-Redox Catalyst for Synergetic Multi-Mode Cancer Photo-Therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Coumarins; Iridium; Mice; Neoplasms; Oxidation-Reduction | 2022 |
Cyclometalated Iridium(III) Complex-Cationic Peptide Hybrids Trigger Paraptosis in Cancer Cells via an Intracellular Ca
Topics: A549 Cells; Apoptosis; Calcium; Calmodulin; Cell Death; Cell Line, Tumor; Curcumin; Endoplasmic Reticulum; HeLa Cells; Humans; Iridium; Jurkat Cells; K562 Cells; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms; Pentacyclic Triterpenes; Signal Transduction; Triterpenes; U937 Cells | 2021 |
Ferroptosis-Enhanced Cancer Immunity by a Ferrocene-Appended Iridium(III) Diphosphine Complex.
Topics: Ferroptosis; Humans; Immunotherapy; Iridium; Lipid Peroxidation; Metallocenes; Neoplasms; Tumor Microenvironment | 2022 |
Photodecaging of a Mitochondria-Localized Iridium(III) Endoperoxide Complex for Two-Photon Photoactivated Therapy under Hypoxia.
Topics: Animals; Cell Line, Tumor; Hypoxia; Iridium; Mice; Mitochondria; Neoplasms; Photochemotherapy; Photosensitizing Agents; Prodrugs; Singlet Oxygen | 2022 |
Systematic Study on the Cytotoxic Potency of Commonly Used Dimeric Metal Precursors in Human Cancer Cell Lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Iridium; Neoplasms; Osmium; Rhodium; Ruthenium | 2022 |
Single-Cell Quantification of a Highly Biocompatible Dinuclear Iridium(III) Complex for Photocatalytic Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Iridium; Lysosomes; Mice; Neoplasms | 2022 |
Iridium(III)-Cp*-(imidazo[4,5-
Topics: Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Glutathione; Humans; Hypoxia; Iridium; Mitochondria; Neoplasms; Neoplastic Stem Cells; Phenol | 2022 |
Rational design of mitochondria targeted thiabendazole-based Ir(III) biscyclometalated complexes for a multimodal photodynamic therapy of cancer.
Topics: Antineoplastic Agents; Coordination Complexes; Iridium; Mitochondria; Neoplasms; Photochemotherapy; Photosensitizing Agents; Thiabendazole | 2022 |
Design and synthesis of aptamer-cyclometalated iridium(III) complex conjugate targeting cancer cells.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Cell Line, Tumor; Drug Delivery Systems; Iridium; Mitochondria; Neoplasms | 2022 |
An Enhanced Photothermal Therapeutic Iridium Hybrid Platform Reversing the Tumor Hypoxic Microenvironment.
Topics: Cell Line, Tumor; Humans; Hydrogen Peroxide; Hypoxia; Iridium; Nanoparticles; Neoplasms; Tumor Microenvironment | 2022 |
Photocatalytic glucose-appended bio-compatible Ir(III) anticancer complexes.
Topics: Antineoplastic Agents; Coordination Complexes; Glucose; Humans; Iridium; Mitochondria; Neoplasms | 2022 |
A cyclometallated iridium(III) complex with multi-photon absorption properties as an imaging-guided photosensitizer.
Topics: Biotin; Humans; Iridium; Neoplasms; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen | 2022 |
Potent anticancer activity of a novel iridium metallodrug via oncosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Death; Cell Line, Tumor; Iridium; Necrosis; Neoplasms | 2022 |
Bioactive Iridium Nanoclusters with Glutathione Depletion Ability for Enhanced Sonodynamic-Triggered Ferroptosis-Like Cancer Cell Death.
Topics: Cell Death; Ferroptosis; Glutathione; Humans; Iridium; Neoplasms; Oxygen; Reactive Oxygen Species | 2022 |
Simultaneous Probing of Metabolism and Oxygenation of Tumors In Vivo Using FLIM of NAD(P)H and PLIM of a New Polymeric Ir(III) Oxygen Sensor.
Topics: Animals; Hypoxia; Iridium; Mice; Microscopy, Fluorescence; NAD; Neoplasms; Oxygen | 2022 |
Self-Amplifying Iridium(III) Photosensitizer for Ferroptosis-Mediated Immunotherapy Against Transferrin Receptor-Overexpressing Cancer.
Topics: Iridium; Neoplasms; Photosensitizing Agents; Receptors, Transferrin | 2022 |
Acidity-Biodegradable Iridium-Coordinated Nanosheets for Amplified Ferroptotic Cell Death Through Multiple Regulatory Pathways.
Topics: Apoptosis; Cell Death; Glutathione; Hemin; Humans; Iridium; Neoplasms; Reactive Oxygen Species | 2023 |
Topics: Apoptosis; Cell Line, Tumor; Humans; Iridium; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2023 |
Boosting Ferroptosis Therapy with Iridium Single-Atom Nanocatalyst in Ultralow Metal Content.
Topics: Animals; Carbon; Catalysis; Cell Line, Tumor; Coloring Agents; Disease Models, Animal; Ferroptosis; Glutathione; Iridium; Mice; Neoplasms; Tumor Microenvironment | 2023 |
Development of Wireless Power-Transmission-Based Photodynamic Therapy for the Induction of Cell Death in Cancer Cells by Cyclometalated Iridium(III) Complexes.
Topics: Cell Death; Cell Line, Tumor; Coordination Complexes; Humans; Iridium; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2023 |
2D Nano-Sonosensitizers Facilitate Energy Transfer to Enhance Sonodynamic Therapy.
Topics: Animals; Iridium; Mice; Neoplasms; Oxygen; Porphyrins; Singlet Oxygen; Ultrasonic Therapy | 2023 |
Tracking chromatin state changes using nanoscale photo-proximity labelling.
Topics: Cell Nucleus; Chromatin; Cross-Linking Reagents; Energy Transfer; Epigenomics; Humans; Inteins; Iridium; Mutation; Neoplasms; Photosensitizing Agents; Protein Binding; Protein Interaction Maps | 2023 |
Photoactivation of Boronic Acid Prodrugs via a Phenyl Radical Mechanism: Iridium(III) Anticancer Complex as an Example.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Cell Line, Tumor; Humans; Iridium; Mice; Neoplasms; Prodrugs; Reactive Oxygen Species; Tumor Microenvironment | 2023 |
Light-Elicited and Oxygen-Saved Iridium Nanocapsule for Oxidative Damage Intensified Oncotherapy.
Topics: Cell Line, Tumor; Humans; Iridium; Nanocapsules; Neoplasms; Oxidative Stress; Oxygen; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2023 |
Exosome camouflaged coordination-assembled Iridium(III) photosensitizers for apoptosis-autophagy-ferroptosis induced combination therapy against melanoma.
Topics: Animals; Apoptosis; Cell Line, Tumor; Exosomes; Ferric Compounds; Ferroptosis; Iridium; Melanoma; Mice; Neoplasms; Photochemotherapy; Photosensitizing Agents; Tumor Microenvironment | 2023 |
Iridium nanozyme-mediated photoacoustic imaging-guided NIR-II photothermal therapy and tumor microenvironment regulation for targeted eradication of cancer stem cells.
Topics: Cell Line, Tumor; Humans; Iridium; Nanoparticles; Neoplasms; Neoplastic Stem Cells; Oxygen; Photoacoustic Techniques; Photothermal Therapy; Reactive Oxygen Species; Tumor Microenvironment | 2023 |
Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Iridium; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria; Naphthalimides; Neoplasms; Ruthenium | 2019 |
Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.
Topics: Anti-Infective Agents; Boron Compounds; Cell Line, Tumor; Cell Survival; Coordination Complexes; Humans; Iridium; Ligands; Light; Methane; Neoplasms; Photochemotherapy; Photosensitizing Agents; Quantum Theory; Reactive Oxygen Species; Staphylococcus aureus; Theranostic Nanomedicine | 2019 |
Construction of Nucleus-Targeting Iridium Nanocrystals for Photonic Hyperthermia-Synergized Cancer Radiotherapy.
Topics: Animals; Cell Line, Tumor; Cell Nucleus; Cell Survival; Female; Hyperthermia, Induced; Iridium; Mice, Nude; Nanoparticles; Neoplasms; Photons; Spectrophotometry, Ultraviolet | 2019 |
Unambiguous Intracellular Localization and Quantification of a Potent Iridium Anticancer Compound by Correlative 3D Cryo X-Ray Imaging.
Topics: Humans; Iridium; Neoplasms; Tomography, X-Ray | 2020 |
Thiourea and Guanidine Compounds and Their Iridium Complexes in Drug-Resistant Cancer Cell Lines: Structure-Activity Relationships and Direct Luminescent Imaging.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Guanidine; Humans; Iridium; Microscopy, Confocal; Molecular Structure; Neoplasms; Optical Imaging; Structure-Activity Relationship; Thiourea | 2020 |
Iridium(III) coordination of N(6) modified adenine derivatives with aminoacid chains.
Topics: A549 Cells; Adenine; Antineoplastic Agents; Coordination Complexes; HeLa Cells; Humans; Iridium; MCF-7 Cells; Molecular Docking Simulation; Neoplasms | 2020 |
Specific "Unlocking" of a Nanozyme-Based Butterfly Effect To Break the Evolutionary Fitness of Chaotic Tumors.
Topics: Adaptation, Physiological; Biocatalysis; Biomimetic Materials; Cell Line, Tumor; Evolution, Molecular; Glucose Oxidase; Glutathione; Humans; Iridium; Nanoparticles; Neoplasms; Peroxidase; Reactive Oxygen Species | 2020 |
Water-soluble cyclometalated Ir(III) complexes as carrier-free and pure nanoparticle photosensitizers for photodynamic therapy and cell imaging.
Topics: Antineoplastic Agents; Cell Membrane Permeability; Coordination Complexes; Drug Development; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Iridium; Light; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Solubility; Structure-Activity Relationship; Water | 2020 |
Hollow Bimetallic Complex Nanoparticles for Trimodality Imaging and Photodynamic Therapy In Vivo.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Holmium; Humans; Indicators and Reagents; Iridium; Ligands; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Molecular Structure; Multimodal Imaging; Neoplasms; Optical Imaging; Photochemotherapy; Singlet Oxygen; Ultrasonography | 2020 |
The design of cyclometalated iridium(iii)-metformin complexes for hypoxic cancer treatment.
Topics: Antineoplastic Agents; Cell Line; Cisplatin; Coordination Complexes; Humans; Iridium; Metformin; Neoplasm Metastasis; Neoplasms; Organometallic Compounds; Tumor Hypoxia; Tumor Microenvironment | 2021 |
Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex.
Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Carriers; Drug Liberation; Hemolysis; Iridium; Liposomes; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neoplasms; NIH 3T3 Cells; Reactive Oxygen Species; Signal Transduction; Xenograft Model Antitumor Assays | 2021 |
Mitochondria specific highly cytoselective iridium(iii)-Cp* dipyridophenazine (dppz) complexes as cancer cell imaging agents.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; DNA; Fluorescent Dyes; Humans; Iridium; Mitochondria; Neoplasms; Organometallic Compounds; Phenazines; Protein Binding | 2021 |
Phosphorescent Ir(III) complexes conjugated with oligoarginine peptides serve as optical probes for in vivo microvascular imaging.
Topics: Animals; Cell Line; Diet, High-Fat; HCT116 Cells; Humans; Iridium; Kidney; Lipid Droplets; Liver; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Molecular Probes; Neoplasm Transplantation; Neoplasms; Pancreas; Peptides; Staining and Labeling | 2021 |
3D CoPt nanostructures hybridized with iridium complexes for multimodal imaging and combined photothermal-chemotherapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cobalt; Combined Modality Therapy; Coordination Complexes; Drug Delivery Systems; Drug Therapy, Combination; Humans; Iridium; Mice; Multimodal Imaging; Nanoparticles; Neoplasms; Photoacoustic Techniques; Photothermal Therapy; Platinum; Povidone; Theranostic Nanomedicine | 2021 |
Light-Driven Cascade Mitochondria-to-Nucleus Photosensitization in Cancer Cell Ablation.
Topics: Ablation Techniques; Cell Line, Tumor; Cell Nucleus; Humans; Iridium; Mitochondria; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2021 |
An Iridium Complex as an AIE-active Photosensitizer for Image-guided Photodynamic Therapy.
Topics: Animals; Crystallization; Iridium; Mice; Models, Molecular; Molecular Structure; Neoplasms; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents | 2021 |
Water-Soluble Iridic-Porphyrin Complex for Non-invasive Sonodynamic and Sono-oxidation Therapy of Deep Tumors.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Iridium; Mice; NAD; Neoplasms; Oxidation-Reduction; Porphyrins; Radiation-Sensitizing Agents; Singlet Oxygen; Ultrasonic Waves; Zebrafish | 2021 |
Cancer cell membrane camouflaged iridium complexes functionalized black-titanium nanoparticles for hierarchical-targeted synergistic NIR-II photothermal and sonodynamic therapy.
Topics: Animals; Cell Line, Tumor; Cell Membrane; Iridium; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Phototherapy; Titanium | 2021 |
Highly Efficient Far-Red/NIR-Absorbing Neutral Ir(III) Complex Micelles for Potent Photodynamic/Photothermal Therapy.
Topics: Animals; Boron Compounds; Cell Line, Tumor; Cell Survival; Coordination Complexes; Humans; Infrared Rays; Iridium; Mice; Micelles; Neoplasms; Photochemotherapy; Photothermal Therapy; Singlet Oxygen | 2021 |
Synthesis of iridium-based nanocomposite with catalase activity for cancer phototherapy.
Topics: Animals; Biocompatible Materials; Catalase; Cell Line, Tumor; Chlorophyllides; Female; Hydrogen Peroxide; Iridium; Light; Mice; Nanocomposites; Nanoparticles; Neoplasms; Oxygen; Photochemotherapy; Porphyrins; Silicon Dioxide; Tumor Microenvironment | 2021 |
A Comparative Analysis of the In Vitro Anticancer Activity of Iridium(III) {η
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Coordination Complexes; Humans; Iridium; Ligands; Mice; Models, Molecular; Neoplasms; Rats; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
Functionalizing Collagen with Vessel-Penetrating Two-Photon Phosphorescence Probes: A New In Vivo Strategy to Map Oxygen Concentration in Tumor Microenvironment and Tissue Ischemia.
Topics: Blood Vessels; Collagen; Humans; Iridium; Luminescent Agents; Microscopy, Confocal; Neoplasms; Oxygen; Photons; Rhenium; Tumor Hypoxia; Tumor Microenvironment | 2021 |
Reduction- and pH-Sensitive Hyaluronan Nanoparticles for Delivery of Iridium(III) Anticancer Drugs.
Topics: A549 Cells; Antineoplastic Agents; Delayed-Action Preparations; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Iridium; Neoplasms; Organometallic Compounds | 2017 |
Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Profiling; Humans; Iridium; Neoplasms; Organometallic Compounds; Osmium; Pharmacogenomic Testing; Tumor Cells, Cultured | 2018 |
Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target.
Topics: Antineoplastic Agents; Cell Survival; Coordination Complexes; Humans; Iridium; Molecular Structure; Neoplasms; Photochemotherapy; Photosensitizing Agents; Quantum Theory; Thermodynamics | 2018 |
Real-Time Multimodal Bioimaging of Cancer Cells and Exosomes through Biosynthesized Iridium and Iron Nanoclusters.
Topics: Exosomes; Humans; Iridium; Iron; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasms | 2018 |
Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Iridium; Mitochondria; Models, Molecular; Neoplasms; Neoplastic Stem Cells; Phenanthrolines; Reactive Oxygen Species | 2018 |
Extending Hypochlorite Sensing from Cells to Elesclomol-Treated Tumors in Vivo by Using a Near-Infrared Dual-Phosphorescent Nanoprobe.
Topics: Animals; Cell Line, Tumor; Cell Survival; HeLa Cells; Humans; Hydrazines; Hypochlorous Acid; Infrared Rays; Iridium; Luminescence; Mice; Nanoparticles; Neoplasms | 2018 |
Rational Design of Phosphorescent Iridium(III) Complexes for Selective Glutathione Sensing and Amplified Photodynamic Therapy.
Topics: 3T3-L1 Cells; Animals; Apoptosis; Cell Line, Tumor; Coordination Complexes; Density Functional Theory; Glutathione; Humans; Iridium; Light; Mice; Microscopy, Confocal; Neoplasms; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2019 |
Half-sandwich iridium(III) complexes with α-picolinic acid frameworks and antitumor applications.
Topics: A549 Cells; Antineoplastic Agents; Coordination Complexes; Humans; Iridium; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms; Picolinic Acids | 2019 |
Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated Ir
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Survival; Coordination Complexes; Coumarins; HeLa Cells; Humans; Iridium; Light; Neoplasms; Photochemotherapy; Superoxides | 2019 |
Anticancer Ir
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Aspirin; Cell Line, Tumor; Cell Survival; Coordination Complexes; Female; Humans; Immunomodulation; Iridium; Luminescent Measurements; Mice, Inbred BALB C; Mitochondria; Neoplasms; Optical Imaging | 2019 |
Theoretical insight into the photophysical properties of long-lifetime Ir(iii) and Rh(iii) complexes for two-photon photodynamic therapy.
Topics: Benzimidazoles; Coordination Complexes; Humans; Iridium; Models, Molecular; Neoplasms; Photochemotherapy; Photosensitizing Agents; Pyridines; Quantum Theory; Rhodium | 2019 |
Photostable Iridium(III)-Cyanine Complex Nanoparticles for Photoacoustic Imaging Guided Near-Infrared Photodynamic Therapy in Vivo.
Topics: Animals; Carbocyanines; Cell Line, Tumor; Cell Survival; Coordination Complexes; Half-Life; Humans; Iridium; Lasers; Nanoparticles; Neoplasms; Optical Imaging; Photoacoustic Techniques; Photochemotherapy; Singlet Oxygen; Tissue Distribution; Transplantation, Heterologous | 2019 |
Amphiphilic Gemini Iridium(III) Complex as a Mitochondria-Targeted Theranostic Agent for Tumor Imaging and Photodynamic Therapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Coordination Complexes; Humans; Iridium; Light; Mice; Mice, Nude; Mitochondria; Neoplasms; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Quaternary Ammonium Compounds; Singlet Oxygen; Theranostic Nanomedicine; Transplantation, Heterologous | 2019 |
Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents.
Topics: A549 Cells; Amination; Antineoplastic Agents; Cell Survival; Coordination Complexes; Crystallography, X-Ray; HeLa Cells; Hep G2 Cells; Humans; Imines; Iridium; Models, Molecular; Neoplasms; Ruthenium | 2019 |
Design, synthesis, and evaluation of phosphorescent Ir(III) complexes with anticancer activity.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Coordination Complexes; Fluorescent Dyes; Humans; Iridium; Lysosomes; Neoplasms; Reactive Oxygen Species | 2019 |
Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coordination Complexes; Female; Humans; Iridium; Mitochondria; Neoplasms; Ovarian Neoplasms; Ovary | 2013 |
Hypoxia-sensitive bis(2-(2'-benzothienyl)pyridinato-N,C(3'))iridium[poly(n-butyl cyanoacrylate]/chitosan nanoparticles and their phosphorescence tumor imaging in vitro and in vivo.
Topics: Animals; Cell Hypoxia; Cells, Cultured; Chitosan; Coordination Complexes; Drug Carriers; Enbucrilate; HeLa Cells; Humans; Iridium; Luminescent Agents; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; Nanoparticles; Neoplasms; Oxygen | 2013 |
Biocompatible and highly luminescent near-infrared CuInS₂/ZnS quantum dots embedded silica beads for cancer cell imaging.
Topics: Biocompatible Materials; Copper; Diagnostic Imaging; HeLa Cells; Humans; Hydrodynamics; Hydrophobic and Hydrophilic Interactions; Iridium; Luminescence; Micelles; Nanoparticles; Neoplasms; Quantum Dots; Silicon Dioxide; Spectroscopy, Near-Infrared; Sulfides; Ultrasonics; Zinc Compounds | 2014 |
An activatable, polarity dependent, dual-luminescent imaging agent with a long luminescence lifetime.
Topics: Animals; Breast Neoplasms; Carbocyanines; Cell Line; Cell Line, Tumor; Coordination Complexes; Female; Iridium; Luminescence; Luminescent Agents; Luminescent Measurements; Mice; Microscopy, Confocal; Neoplasms; Optical Imaging | 2014 |
Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Coordination Complexes; Female; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Iridium; Ligands; Neoplasms; Photochemotherapy; Singlet Oxygen | 2014 |
Phosphorescent polymeric nanoparticles by coordination cross-linking as a platform for luminescence imaging and photodynamic therapy.
Topics: Coordination Complexes; HeLa Cells; Humans; Iridium; Luminescence; Microscopy, Confocal; Nanoparticles; Neoplasms; Optical Imaging; Photochemotherapy; Polyethylene Glycols; Vinyl Compounds | 2014 |
A metal-containing nucleoside that possesses both therapeutic and diagnostic activity against cancer.
Topics: Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Cells, Cultured; Cytosol; Dose-Response Relationship, Drug; Equilibrative Nucleoside Transporter 1; G2 Phase Cell Cycle Checkpoints; Humans; Iridium; Metals; Microscopy, Fluorescence; Mitochondria; Necrosis; Neoplasms; Nucleosides; RNA Interference; Time Factors | 2015 |
Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; DNA Breaks, Single-Stranded; Humans; Hypoxia; Iridium; Models, Molecular; Neoplasms; Ruthenium | 2015 |
Azo-Based Iridium(III) Complexes as Multicolor Phosphorescent Probes to Detect Hypoxia in 3D Multicellular Tumor Spheroids.
Topics: Animals; Cell Survival; Fluorescent Dyes; Humans; Hypoxia; Iridium; Microsomes; Molecular Conformation; Molecular Imaging; Neoplasms; Oxidation-Reduction; Rats; Spheroids, Cellular; Tumor Cells, Cultured | 2015 |
Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Humans; Iridium; Neoplasms; Organometallic Compounds; Protein Interaction Domains and Motifs; Proto-Oncogene Proteins c-mdm2; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2016 |
Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer agents.
Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; Female; HeLa Cells; Hep G2 Cells; Humans; Iridium; MCF-7 Cells; Mitochondria; Neoplasms | 2016 |
Metal Complexes for Two-Photon Photodynamic Therapy: A Cyclometallated Iridium Complex Induces Two-Photon Photosensitization of Cancer Cells under Near-IR Light.
Topics: Apoptosis; Cell Line, Tumor; Coordination Complexes; Humans; Iridium; Light; Neoplasms; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen | 2017 |
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
Topics: A549 Cells; Antineoplastic Agents; Coordination Complexes; Drug Delivery Systems; Drug Resistance, Neoplasm; HeLa Cells; Hep G2 Cells; Humans; Iridium; MCF-7 Cells; Mitochondria; Neoplasms | 2016 |
Cationic Amphiphilic Tris-Cyclometalated Iridium(III) Complexes Induce Cancer Cell Death via Interaction with Ca
Topics: Animals; Antineoplastic Agents; Azirines; Calcium; Calmodulin; Cell Death; Coordination Complexes; Humans; Iridium; Jurkat Cells; Models, Molecular; Neoplasms | 2017 |
Real-Time Verification of a High-Dose-Rate Iridium 192 Source Position Using a Modified C-Arm Fluoroscope.
Topics: Computer Systems; Equipment Design; Equipment Failure Analysis; Fluoroscopy; Humans; Iridium; Neoplasms; Radiation Dosage; Radioisotopes; Radiometry; Radiotherapy Dosage; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2017 |
Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
Topics: Antineoplastic Agents; Caspase 3; Caspase 7; Cell Death; Cell Line, Tumor; Cells, Cultured; Circular Dichroism; Coordination Complexes; Crystallography, X-Ray; DNA; HeLa Cells; Humans; Iridium; Models, Molecular; Naphthoquinones; Neoplasms; Rhodium | 2010 |
Phosphorescent light-emitting iridium complexes serve as a hypoxia-sensing probe for tumor imaging in living animals.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Female; HeLa Cells; HT29 Cells; Humans; Iridium; Luminescent Measurements; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Organometallic Compounds; Oxygen; Partial Pressure; Photochemical Processes; Pyridines; Thiophenes; Tissue Distribution; Transplantation, Heterologous | 2010 |
Trapping unstable benzoquinone analogues by coordination to a [(η(5)-C(5)Me(5))Ir] fragment and the anticancer activity of the resulting complexes.
Topics: Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Coordination Complexes; Humans; Iridium; Neoplasms; Rhodium | 2010 |
A novel electrochemiluminescent reagent of cyclometalated iridium complex-based DNA biosensor and its application in cancer cell detection.
Topics: Biosensing Techniques; Cell Separation; DNA; Electrochemistry; HeLa Cells; Humans; Indicators and Reagents; Iridium; Luminescent Agents; Neoplasms; Organometallic Compounds | 2011 |
[Technic of plesiocurietherapy of cancers of the maxillary sinus by iridium-192 wires].
Topics: Facial Neoplasms; Humans; Iridium; Iridium Radioisotopes; Maxillary Sinus; Neoplasms | 1962 |
Radium substitutes in the interstitial implantation of tumors--with particular reference to iridium-192.
Topics: Humans; Iridium; Neoplasms; Radium | 1963 |
USE OF ARTIFICIAL RADIO-ISOTOPES IN INTERSTITIAL RADIOTHERAPY.
Topics: Abdominal Neoplasms; Brachytherapy; Breast Neoplasms; Cobalt Isotopes; Gold Isotopes; Humans; Iridium; Isotopes; Lung Neoplasms; Mastectomy; Neoplasms; Radiography, Thoracic; Radioisotopes; Radium; Radon | 1963 |
[CURIE-LIKE THERAPY OF CANCERS OF THE CAVUM WITH PLASTIC TUBING AND IRIDIUM-192].
Topics: Humans; Iridium; Iridium Radioisotopes; Nasopharyngeal Neoplasms; Neoplasms; Nylons; Plastics | 1963 |
RADIOACTIVE ISOTOPES IN MEDICINE. THERAPEUTIC USES OF RADIOACTIVE ISOTOPES.
Topics: Cesium Isotopes; Chemotherapy, Cancer, Regional Perfusion; Cobalt Isotopes; Gold Isotopes; Humans; Iodine Isotopes; Iridium; Lymphography; Neoplasms; Phosphorus Isotopes; Radioisotopes; Tantalum; Urinary Bladder Neoplasms; Yttrium Isotopes | 1964 |
[TREATMENT WITH RADIOISOTOPES].
Topics: Ascites; Chromium Isotopes; Gold Isotopes; Heart Failure; Humans; Hydrothorax; Hyperthyroidism; Iodine Isotopes; Iridium; Lutetium; Myocardial Infarction; Neoplasms; Phosphorus Isotopes; Radioisotopes; Radiotherapy; Tantalum; Thyroid Neoplasms; Yttrium Isotopes | 1963 |
AFTERLOADING APPLICATOR FOR TREATMENT OF CANCER OF THE UTERUS.
Topics: Cesium Isotopes; Cobalt Isotopes; Equipment and Supplies; Europium; Female; Humans; Iridium; Neoplasms; Radiation Protection; Radium; Tantalum; Uterine Neoplasms | 1964 |
TREATMENT OF ANTRAL CARCINOMA WITH RADIOACTIVE IRIDUM.
Topics: Anemia, Iron-Deficiency; Carcinoma; Humans; Iridium; Maxillary Neoplasms; Maxillary Sinus; Neoplasms; Radiography; Radioisotopes | 1964 |
INTRACAVITARY IRRADIATION OF MALIGNANT BRAIN TUMOURS.
Topics: Adolescent; Astrocytoma; Brain Neoplasms; Cesium Isotopes; Dura Mater; Frontal Lobe; Glioblastoma; Glioma; Humans; Iridium; Necrosis; Neoplasms; Neurosurgery; Pathology; Radiation Injuries; Radioisotopes | 1963 |
REMOTE AFTERLOADING WITH INTRACAVITARY APPLICATORS.
Topics: Cesium Isotopes; Cobalt Isotopes; Equipment and Supplies; Female; Humans; Iridium; Neoplasms; Radiation Protection; Radioisotope Teletherapy; Radioisotopes; Radiology; Radiotherapy; Radium; Technology, Radiologic; Uterine Cervical Neoplasms | 1964 |
[CAN IRIDIUM-192 REPLACE RADIUM?].
Topics: Humans; Iridium; Iridium Radioisotopes; Neoplasms; Radium | 1965 |
IRIDIUM 192 AS A RADIUM SUBSTITUTE.
Topics: Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Geriatrics; Humans; Iridium; Iridium Radioisotopes; Lymphatic Metastasis; Nasopharyngeal Neoplasms; Neoplasms; Palliative Care; Radioisotopes; Radiotherapy Dosage; Radium; Thyroid Neoplasms; Tongue Neoplasms; Urethral Neoplasms | 1965 |
["BLIND END" TECHNIC FOR INTERSTITIAL IMPLANTS OF REMOVABLE NYLON RIBBONS CHARGED WITH IRIDIUM. ITS APPLICATION IN CARCINOMA OF THE RECTUM AND VAGINA].
Topics: Carcinoma; Female; Humans; Iridium; Neoplasms; Nylons; Radium; Rectal Neoplasms; Rectum; Vaginal Neoplasms | 1964 |
TREATMENT OF INTERNAL MAMMARY NODES WITH A RADIOACTIVE WIRE.
Topics: Breast Neoplasms; Catheterization; Cobalt Isotopes; Humans; Iridium; Lymphatic Metastasis; Mastectomy; Neoplasms; Radioactivity; Tantalum; Thoracic Arteries | 1964 |
[STANDARD CIRCULAR ISODOSES IN INTRACAVITARY AND CONTACT RADIOTHERAPY; TECHNICAL NOTE].
Topics: Humans; Iridium; Neoplasms; Radiometry; Radiotherapy Dosage; Tomography; X-Ray Therapy | 1964 |
NEW METHOD OF TREATING MELANOMA OF THE PECTORAL REGION.
Topics: Axilla; Breast Neoplasms; Cobalt Isotopes; Humans; Iridium; Lymph Node Excision; Mastectomy; Melanoma; Neck Dissection; Neoplasms; Thoracic Neoplasms | 1965 |
[ENDOCURIETHERAPY OF CANCEROUS CERVICAL ADENOPATHIES WITH GOLD-198 OR IRIDIUM-192].
Topics: Gold Isotopes; Gold Radioisotopes; Head and Neck Neoplasms; Humans; Iridium; Lymphatic Metastasis; Neoplasms; Radiography | 1964 |
[CAN IRIDIUM 192 REPLACE RADIUM?].
Topics: Humans; Iridium; Iridium Radioisotopes; Neoplasms; Radium | 1965 |
[Permanent interstitial implant with radioactive seeds of long and low energy].
Topics: Gold Isotopes; Humans; Iodine Isotopes; Iridium; Neoplasms; Radioisotopes; Radon | 1967 |
[Modern trends in curietherapy].
Topics: Humans; Iridium; Neoplasms; Radioisotopes; Radium | 1967 |
Interstitial thermoradiotherapy in the treatment of recurrent/residual malignant tumors.
Topics: Adult; Aged; Brachytherapy; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Iridium; Male; Middle Aged; Neoplasms; Radioisotopes | 1984 |
Interstitial hyperthermia and interstitial iridium 192 implantation: a technique and preliminary results.
Topics: Animals; Brachytherapy; Electrodes, Implanted; Hot Temperature; Humans; Iridium; Neoplasms; Radioisotopes; Radiotherapy, High-Energy; Swine | 1981 |
[Position of interstitial iridium brachytherapy].
Topics: Brachytherapy; Humans; Iridium; Neoplasms; Radioisotopes | 1981 |
The destiny of brachytherapy in oncology.
Topics: Europe; History, 19th Century; History, 20th Century; Humans; Iridium; Neoplasms; Radioisotopes; Radiotherapy; Radiotherapy Dosage | 1976 |
[A projector of iridium 192 wires: motivations and preliminary studies (author's transl)].
Topics: Aged; Brachytherapy; Humans; Infant; Iridium; Neoplasms; Radiation Protection; Radioisotopes | 1979 |
[Introduction to the use of 125 iodine in interstitial radiotherapy (author's transl)].
Topics: Brachytherapy; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Iridium; Lung Neoplasms; Male; Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radon | 1979 |
[Computerised dosimetry in interstitial management with 192Ir sources (author's transl)].
Topics: Computers; Electronics, Medical; Humans; Iridium; Neoplasms; Radioisotopes; Radiotherapy Dosage; Tongue Neoplasms | 1977 |
[Section of Oncological Radiotherapy of SIRMN. Report on the current status of oncological radiotherapy in public hospitals in Italy].
Topics: Cesium Radioisotopes; Cobalt Radioisotopes; Humans; Iridium; Italy; Neoplasms; Radioisotopes; Radiotherapy Dosage; Radium; X-Ray Therapy | 1978 |
Radiotherapy with interstitial implants.
Topics: Anesthesia, General; Cobalt Radioisotopes; Humans; Iridium; Methods; Neoplasms; Radioisotopes; Radium; Tantalum | 1977 |
Technique of after-loading interstitial implants.
Topics: Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Humans; Iodine Radioisotopes; Iridium; Liposarcoma; Male; Methods; Mouth Neoplasms; Neoplasms; Pancreatic Neoplasms; Pharyngeal Neoplasms; Radioisotopes; Radiotherapy; Rectal Neoplasms | 1977 |
Interstitial therapy suing non-absorbable (Ir192 nylon ribbon) and absrobable (I125 "Vicryl") suturing techniques.
Topics: Humans; Iodine Radioisotopes; Iridium; Neoplasms; Nylons; Suture Techniques; Sutures | 1975 |
[Interstitial Iridium-192 treatment].
Topics: Humans; Iridium; Methods; Neoplasms; Radium | 1975 |
An integrated system for interstitial 192Ir implants.
Topics: Brachytherapy; Humans; Iridium; Neoplasms; Radioisotopes | 1987 |
The cost of interstitial curietherapy using iridium pins and needles.
Topics: Brachytherapy; Costs and Cost Analysis; Humans; Iridium; Neoplasms; Radioisotopes | 1987 |
[A new method of mechanical afterloading--procedure for iridium wires].
Topics: Brachytherapy; Humans; Iridium; Neoplasms; Quality Control; Radioisotopes; Radiotherapy Dosage | 1986 |
Iridium afterloading curietherapy in the treatment of pediatric malignancies. The Institut Gustave Roussy experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Child; Child, Preschool; Combined Modality Therapy; Evaluation Studies as Topic; Female; Follow-Up Studies; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Infant; Infant, Newborn; Iridium; Isotopes; Male; Mesonephroma; Neoplasms; Pelvic Neoplasms; Rhabdomyosarcoma | 1985 |
Routine quality control of Ir-192 sources: results of 46 months of surveillance.
Topics: Brachytherapy; Calibration; Humans; Iridium; Neoplasms; Quality Control; Radioisotopes | 1985 |
Comparative dosimetry between iridium wires and seed ribbons.
Topics: Brachytherapy; Humans; Iridium; Neoplasms; Radioisotopes; Radiotherapy Dosage | 1985 |
[Current indications for and use of high energy ionizing radiations].
Topics: Bone Neoplasms; Breast Neoplasms; Cesium; Cobalt Radioisotopes; Female; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Iridium; Lymphoma; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms; Radiobiology; Radioisotope Teletherapy; Radium; Respiratory Tract Neoplasms; Skin Neoplasms; Spinal Cord Neoplasms; Urogenital Neoplasms | 1974 |
Solid geometry versus plane geometry for 252 Cf sources.
Topics: Californium; Iridium; Mathematics; Neoplasms; Platinum; Radiotherapy Dosage | 1972 |
Use of iridium-192 in interstitial tumor therapy.
Topics: Aged; Anus Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Cobalt Isotopes; Female; Humans; Iridium; Lip Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasms; Parotid Neoplasms; Radioisotope Teletherapy; Radioisotopes; Radiotherapy Dosage; Rectal Neoplasms; Skin Neoplasms; Tongue Neoplasms; Urethral Neoplasms | 1973 |
Some modifications to existing iridium-192 wire after-loading techniques.
Topics: Iridium; Methods; Neoplasms; Nylons; Radioisotopes | 1974 |
A tentative analysis of the influence of the time-factor in 192 iridium treatment.
Topics: Cobalt Isotopes; Evaluation Studies as Topic; Humans; Iridium; Mucous Membrane; Necrosis; Neoplasms; Radiation Effects; Radiation Injuries; Radiotherapy Dosage; Skin; Time Factors | 1971 |
[Considerations on the use of non-radioactive preparation technics with solid Ir-192 sources].
Topics: Humans; Iridium; Neoplasms; Radioisotopes; Radiotherapy Dosage | 1966 |
Iridium-192 for tumor implants with direct dose measurements.
Topics: Humans; Iridium; Neoplasms; Radioisotopes; Radiotherapy Dosage | 1967 |
[GammaMed, a new contact irradiation apparatus for interstitial, intracavitary and intraoperative tumor treatment. Physico-technical principles].
Topics: Humans; Iridium; Methods; Neoplasms; Radioisotopes; Radiotherapy | 1969 |
Afterloading techniques.
Topics: Cesium Isotopes; Fibrosarcoma; Humans; Iridium; Neoplasms; Pelvic Neoplasms; Radioisotopes; Radiotherapy; Tantalum | 1970 |
A technique for afterloading implants using radioactive iridium wire.
Topics: Humans; Iridium; Methods; Neoplasms; Radioisotopes; Radiotherapy | 1970 |
Toward consistent local control of certain malignant tumors. Endoradiotherapy with iridium 192.
Topics: Breast Neoplasms; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Ear Neoplasms; Female; Head and Neck Neoplasms; Humans; Iridium; Lip Neoplasms; Male; Methods; Neoplasm Recurrence, Local; Neoplasms; Nose Neoplasms; Palatal Neoplasms; Penile Neoplasms; Radioisotopes; Skin Neoplasms; Technology, Radiologic; Tongue Neoplasms; Tonsillar Neoplasms; Urethral Neoplasms; Vaginal Neoplasms | 1971 |
[Recent trends in curietherapy: Ir 192].
Topics: Female; Humans; Iridium; Neoplasms; Radioisotopes; Radiotherapy Dosage; Radium | 1967 |
Clinical experience with long half-life and low-energy encapsulated radioactive sources in cancer radiation theapy.
Topics: Adult; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Humans; Iodine Isotopes; Iridium; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Radioisotopes; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1968 |
[Place of radiotherapy in the treatment of cancers].
Topics: Cesium; Cobalt; Hodgkin Disease; Humans; Iridium; Neoplasms; Prognosis; Radioisotope Teletherapy; Radioisotopes; Time Factors | 1968 |
[Irradiation of malignant tumors in the field of otorhinolaryngology using radio-controlled iridium-192 contact irradiation].
Topics: Humans; Iridium; Methods; Neoplasms; Otorhinolaryngologic Diseases; Radioisotopes | 1969 |
[Apropos of radium and iridium-192].
Topics: Iridium; Neoplasms; Radiation Protection; Radium | 1965 |
[Recent developments in interstitial curietherapy in the treatment of malignant tumors].
Topics: Cobalt Isotopes; Gold Isotopes; Humans; Iridium; Neoplasms; Radiation Effects; Radiography, Thoracic; Radioisotopes; Radium; Tantalum | 1965 |
[Curietherapy by artificial beta-emitters].
Topics: Humans; Iridium; Neoplasms; Radiotherapy Dosage | 1966 |